Navigation Links
Surefire Medical's Anti-Reflux Infusion System May Eliminate Coiling, Lower Cost Of Embolization Procedures

WESTMINSTER, Colo., Sept. 16, 2013 /PRNewswire/ -- Surefire Medical, Inc., the developer of a brand new class of infusion systems designed to maximize direct-to-tumor drug delivery without reflux, today announced that presentations at the Cardiovascular and Interventional Radiological Society (CIRSE) meeting make the economic case for use of the new Surefire Infusion System (SIS).   Research presented today in Barcelona found that:

  • The SIS catheter group had a significant reduction in procedure time, fluoroscopy time, and contrast dose in pre-treatment angiograms
  • Without use of coils, no non-target embolization occurred in the SIS group during treatment
  • Using the SIS catheter to protect non-target organs costs significantly less than coil embolization in direct-to-tumor cancer treatment

"The Surefire Infusion System is a viable first-line alternative to traditional retrievable coil embolization for protecting non-target organs and may lead to decreased overall costs, procedure time, fluoroscopy time, and contrast exposure when treating cancer patients with radioembolization," said principal investigator Steven Kikolski, MD of the University of California San Diego (UCSD).

Additional SIS-focused presentations at CIRSE

Five additional presentations and posters at CIRSE focusing on the Surefire Infusion System

  • Confirm the safety of performing chemoembolization and radioembolization procedures without coiling
  • Present a pilot study of a single procedure for mapping and radioembolization
  • Detail the new ability to measure blood pressure changes that can signal the endpoint of embolization
  • Discuss the feasibility of bariatric embolization to reduce obesity

"We are extremely gratified by the rapidly growing body of clinical evidence showing that both patients and medical institutions benefit by the use of the Surefire Infusion System for cancer treatment," said Surefire President and CEO Jim Chomas.  "The new technology advances the better tolerated, minimally-invasive embolization techniques.  It reduces procedure time and cost, and makes treatment feasible for patients previously thought untreatable."

About Surefire Medical

Surefire Medical, Inc., based in Westminster, Colo., was founded in 2009 to develop innovative infusion systems for the interventional radiology and interventional oncology markets.  Surefire's infusion systems are designed to precisely deliver embolic agents through a unique microcatheter with an expandable tip that collapses in forward flow and dynamically expands to the vessel wall in reverse flow in order to maximize targeted delivery, minimize reflux and reduce damage to healthy tissue.  The Surefire Infusion System-ST, LT and specialty catheters have received regulatory approval in the U.S., Europe, and New Zealand.  For more information, please visit


SOURCE Surefire Medical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Surefire Medical Launches Next Generation Infusion System ST-LT and Specialty Catheters at SIR - Maximizing Targeted Delivery of Embolics Without Reflux
2. Nile Therapeutics Announces Top-Line Results in Clinical Trial Evaluating the Subcutaneous Infusion of Cenderitide, Meets Primary Endpoint
3. At RSNA, DR Systems Will Exhibit RIS, Reporting, Peer Review Systems
4. Clionsky Neuro Systems (CNS-Neuro) Announces Publication of Study Finding Elderly Patients Unable to Recognize Their Memory Loss
5. Dicom Systems and Announce Partnership and Introduce Beta Version of, New System by
6. Ellmans Pelleve™ Wrinkle Reduction System featured in "Sexy Eyes" segment on The Doctors
7. Bacterin Signs Distribution Agreement with Jeil for LeForte Craniomaxillofacial System
8. BioPower Systems Awarded $5 Million from Victorian Government
9. Echo Therapeutics Announces Positive Results of Clinical Trial of its Symphony® Transdermal Continuous Glucose Monitoring (tCGM) System in Patients With Type 1 and Type 2 Diabetes
10. Varian Medical Systems Schedules First Quarter FY2012 News Release and Conference Call
11. Quanterix Develops Microfluidic Consumable That Will Enable Next Generation Molecular Diagnostic Systems based on Single Molecule Array Technology
Post Your Comments:
(Date:12/1/2015)...  Twist Bioscience, a company focused on synthetic DNA, today ... been selected as one of Foreign Policy,s 100 ... blocks of life . Each year, Foreign Policy ... work have changed lives and are shaping the world. ... honor to be recognized among these incredible global leaders," said ...
(Date:12/1/2015)... 2015  The Minnesota High Tech Association (MHTA) has ... Award in the Small and Growing Healthcare award category. ... Minneapolis Convention Center, the Tekne Awards honor ... in developing new technologies that positively impact the lives ... Clostridium difficile infection ( C. diff. ), ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... (AFM) announces Park NX10 SICM Module, an add-on scanning ion conductance microscopy module ... power of SICM to an AFM. , Park SICM benefits virtually all materials ...
(Date:12/1/2015)... , Dec. 1, 2015  Symic, a clinical-stage ... the extracellular matrix (ECM), today announced that it has ... advance the company,s pipeline, including its lead candidates SB-030 ... and includes the participation by all existing major investors, ... brings the total capital raised by Symic to over ...
Breaking Biology Technology:
(Date:11/17/2015)... 2015 Paris from 17 ... Paris from 17 th until 19 ... innovation leader, has invented the first combined scanner in the ... same scanning surface. Until now two different scanners were required: one ... capture both on the same surface. This innovation is ...
(Date:11/17/2015)... 2015  Vigilant Solutions announces today that Mr. ... Directors. --> --> ... the partnership at TPG Capital, one of the largest ... Billion in revenue.  He founded and led TPG,s Operating ... companies, from 1997 to 2013.  In his first role, ...
(Date:11/16/2015)... 16, 2015  Synaptics Inc. (NASDAQ: SYNA ... today announced expansion of its TDDI product portfolio ... controller and display driver integration (TDDI) solutions designed ... new TDDI products add to the previously-announced ... (WQHD resolution), and TD4322 (FHD resolution) solutions. All ...
Breaking Biology News(10 mins):